Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women

Spine

Volumn 37, Issue 25, 2012, Pages

  Al Shoha, Ahmad ^a   Rao, D Sudhaker ^b   Schilling, Jennifer ^c   Peterson, Edward ^d   Mandel, Shlomo ^c  

^a SUMMA HEALTH SYSTEM   (United States)

^b University of Colorado Anschutz Medical Campus   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Back pain; Bone mineral density; Epidural steroid injection

Indexed keywords

ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; STEROID;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMUR NECK; HIP; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RADICULOPATHY; SPINE;

ABSORPTIOMETRY, PHOTON; ADRENAL CORTEX HORMONES; AGED; ALKALINE PHOSPHATASE; BACK PAIN; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; CASE-CONTROL STUDIES; COLLAGEN TYPE I; FEMALE; FEMUR NECK; HIP JOINT; HUMANS; INJECTIONS, EPIDURAL; PATIENT COMPLIANCE; PATIENT DROPOUTS; PEPTIDES; POSTMENOPAUSE; PROSPECTIVE STUDIES; RADICULOPATHY; RISK FACTORS; SPINE; TIME FACTORS;

EID: 84870858271     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318270280e     Document Type: Article

References (26)

1. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007 ; 147 : 478-91.
2. Dagenais S, Tricco AC, Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J 2010 ; 10 : 514-29.
3. Benny B, Atari P. The efficacy of lumbosacral transforaminal epidural steroid injections: a comprehensive literature review. J Back Musculoskeletal Rehabil 2001 ; 24 : 67-76.
4. Lumbar epidural steroid injections: indications, contraindications, risks and benefits. Curr Sports Med Rep 2010 ; 9 : 43-9
5. Snarr J. Risk, benefits and complications of epidural steroid injections: a case report. AANA J 2007 ; 75 : 183-8.
6. Jacobs JW, de Nijs RN, Lems WF, et al. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. J Rhematol 2007 ; 34 : 5.
7. Woolf A. An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2007 ; 19 : 370-5.
8. Pearce G, Tabensky DA, Delmas PD, et al. Corticosteroid-induced bone loss in men. J Clin Endrocrinol Metab 1998 ; 83 : 801-6.
9. Civitelli R, Armamento-Villareal R, Napoli N. Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 2009 ; 20 : 843-51.
10. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid- induced and postmenopausal osteoporosis. J Bone Miner Res 2001 ; 16 : 97-103
11. Role of 25-hydroxyvitamin D and glucocorticoid dose. ; :. Intestinal calcium absorption in exogenous hypercortisolism. Role of 25-hydroxyvitamin D and glucocorticoid dose. J Clin Invest 1977 ; 60 : 253-9
12. Israel E, Banerjee TR, Fitzmaurice GM, et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001 ; 345 : 941-7.
13. Data abstracted from Henry Ford Health System repository for other studies pending publication.
14. Guthrie JR, Ebeling PR, Hopper JL. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998 ; 8 : 282-90.
15. Ensrud KE, Palermo L, Black D, et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995 ; 10 : 1778-87.
16. Välimäki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994 ; 9 : 631-7.
17. Ensrud KE, Walczak TS, Blackwell T, et al. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 2004 ; 62 : 2051-7.
18. Geisler J, Lomning PE. Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations. J Steroid Mol Biol 2005 ; 95 : 75-81.
19. Eastell R, Hannon RA, Cuzick J, et al. Effect of an aromatase inhibitor on BMD and bone turnover markers; 2-year results of the Anastrozole, Tamoxifen, Alone or in combination (ATAC) trial (18233230). J Bone Miner Res 2006 ; 21 : 1215-23.
20. Weinsten R. Glucocorticoid-induced bone disease. N Engl J Med. 2011 ; 354 : 62-70.
21. Leeming DJ, Alexandersen P, Karsdal MA, et al. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Parmacol 2006 ; 62 : 781-92.
22. Manchikanti L, Pampati V, Beyer C, et al. The effect of neuraxial steroids on weight and bone mass density: a prospective evaluation. Pain Physician 2000 ; 3 : 357-66.
23. Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician 2002 ; 5 : 182-99.
24. Kang S, Hwang B, Son H. Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain. Pain Physician 2012 ; 15 : 229-36.
25. Even JL, Crosby CG, Song Y, et al. Effects of epidural steroid injections on blood glucose levels in patients with diabetes mellitus. Spine (Phila Pa 1976) 2012 ; 37 : E46-50.
26. Payer J, Brazdilova K, Jackuliak P. Management of glucocorticoidinduced osteoporosis: prevalence, and emerging treatment options. Drug Healthc Patient Saf 2010 ; 2 : 49-59.